PNC-27 is a synthetic peptide containing a p53 protein fragment linked to a cell-penetrating sequence. It selectively targets cancer cells that overexpress HDM-2 (a p53 inhibitor), inducing membrane lysis in cancer cells while leaving normal cells unaffected.
Quickstart Highlights
- Dosage: Varies (research)
- Frequency: Research plans
- Administration: Research - various routes
- Cycle length: Research plans only
How This Works
PNC-27 contains an amphipathic peptide that binds to HDM-2 (MDM2), a protein overexpressed on the surface of many cancer cells. When PNC-27 binds to membrane-associated HDM-2, it causes membrane pore formation and necrotic cell death. Normal cells, which don't overexpress HDM-2 on their surface, are unaffected, providing selectivity for cancer cells.
Mechanism of Action
How PNC-27 Works in Your Body
Peptide Administered
Enters the bloodstream via injection
Receptor Binding
Finds and activates its target receptor
Signal Cascade
Triggers a chain of cellular responses
Biological Effect
The body produces the desired outcome
Benefits & Side Effects
Potential Benefits
- Selective cancer cell killing
- Novel mechanism of action
- Does not affect normal cells
- Potential for various cancer types
- Research tool for cancer biology
Potential Side Effects
- Unknown - research compound
- Requires controlled research setting
- Not for human self-administration
- Preclinical safety data only
Good to know
- RESEARCH COMPOUND ONLY - Not approved for human use.
- Contains p53 fragment linked to penetrating sequence.
- Selectively kills cancer cells overexpressing HDM-2.
- Normal cells are not affected.
- Preclinical research only.
- NOT for self-administration.
- Requires medical research setting.
Community Insights
Summarised from 2 sourcesPNC-27 is a synthetic peptide containing a p53 protein fragment linked to a cell-penetrating sequence. It selectively targets cancer cells that overexpress HDM-2 (a p53 inhibitor), inducing membrane lysis in cancer cells while leaving normal cells unaffected. Research compound for cancer. Targets HD
Common Dosages Reported
- Varies (research) Research plans
- Standard protocol dosing
Side Effects Mentioned
- Generally mild, individual variation expected
- See full guide for detailed safety info
Stacking Suggestions
- Consult research and healthcare provider before stacking
What people are saying
Results vary based on individual response
Consistent dosing and timing important
Reviews & Discussion
Real experiences shared by the community — not medical advice.
Successful Skin Cancer Treatment with PNC-27
A user shared a positive experience using PNC-27 to treat a cancerous growth on their face. After several weeks of treatment, the user reported that the cancer was successfully removed and expressed high satisfaction with the results.
PNC-27 Cycle Effectiveness
A user reported that they have been running PNC-27 for several weeks and found it to be helpful, though they noted that the effectiveness seemed to be slowing down over time. They were inquiring whether the peptide requires a cycling protocol to maintain its benefits.
No discussion yet — be the first.
No notes yet — be the first.